August 15, 2023 by Chain Drug Review
Amazon Pharmacy, diabetes, insulin
Leading Headlines, Pharmacy

SEATTLE — Amazon Pharmacy has introduced automatic coupons, providing instant savings on more than 15 insulin and diabetes care brands. Customers can save time and money on the most commonly prescribed products from Novo Nordisk, Eli Lilly, Sanofi, Dexcom, and Insulet — like insulin vials, pens, continuous glucose monitors, and pumps. With automatically applied, manufacturer-sponsored
November 8, 2022 by Chain Drug Review
diabetes, HabitNu
Leading Headlines, Pharmacy, Supplier News

CHICAGO — Chicago-based HabitNu, an organization that promotes healthy lifestyle changes, announced that the American Diabetes Association (ADA) has selected HabitNu as a three-year partner to deliver Project Power, an innovative program to reduce the risk of type 2 diabetes in high-risk and vulnerable communities nationwide. Under this three-year agreement, HabitNu lifestyle coaches will deliver diabetes prevention and
October 26, 2021 by Chain Drug Review
diabetes, Risely Health, Together T1D
Leading Headlines, Pharmacy

NEW YORK — More than a traditional diabetes support organization, Risely Health has been able to disrupt the diabetes health care space by delivering intimate and accessible coaching and resources to people and families impacted by Type 1 Diabetes worldwide. On November 10th from 7-9 pm EST, Risley will be hosting Together T1D, an empowering
March 23, 2021 by Chain Drug Review
Abacus Health Solutions (Abacus), diabetes
Pharmacy, Supplier News

CRANSTON, R.I. — Abacus Health Solutions (Abacus), a pioneer in chronic health condition management, announces the publication of a new applied research article titled “Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs” in the American Journal of Managed Care, March 2021 edition. The study examines the impact of the Abacus Diabetes Care Rewards Program, a care
December 21, 2020 by Chain Drug Review
diabetes, Lisa Hines, Pharmacy Quality Alliance (PQA)
Leading Headlines, Pharmacy

ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA), through a majority vote of its members, has endorsed two new health plan performance measures. The measures evaluate medications to treat individuals with diabetes. More than 34 million Americans have diabetes, according to the Centers for Disease Control and Prevention. These measures will help evaluate the quality of
October 13, 2020 by Chain Drug Review
diabetes, GlucoDown Diabetic Friendly Tea Mix is sugar-free and decaffeinated, Walmart
Leading Headlines, Retail News, Supplier News

BENTONVILLE, Ark.— Soon it will be much easier and more convenient to buy GlucoDown at Walmart. Beginning this month, in-store availability of GlucoDown Diabetic Friendly Peach Tea Mix is expanding to more than 2000 Walmart pharmacies for 2021 – more GlucoDown at more Walmart pharmacies nationwide than ever before. Walmart has stocked GlucoDown Diabetic Friendly Peach
August 31, 2020 by Chain Drug Review
Biocon Biologics India Ltd, diabetes, mylan, Mylan CEO Heather Bresch, Mylan president Rajiv Malik
Leading Headlines, Supplier News

PITTSBURGH— Mylan N.V. and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., announced on Monday the U.S. launch of Semglee (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes. It is not
July 27, 2020 by Chain Drug Review
diabetes, Laura Cranston, PQA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. – Humana, Pfizer and Walgreens are collaborating with the Pharmacy Quality Alliance (PQA) to evaluate the impact of pharmacist-provided care on medication use, health and economic outcomes in patients with diabetes. The project brings together national leaders in pharmacy, care delivery, medications, and health plan administration to demonstrate the value of collaboration between
November 18, 2019 by Scott Howell
diabetes, Echosens, liver diseases, Scott Howell
November 18, 2019, Pharmacy

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NASH). The main risk factors for fatty liver disease include a sedentary
September 23, 2019 by Pooyan Kazemian
Department of Medicine at Harvard Medical School, diabetes, Pooyan Kazemian
Opinion, Pharmacy, September 23, 2019

Adults with diabetes have a two- to three-times increased risk of early death compared to individuals without diabetes. Leaving diabetes uncontrolled can damage the kidneys, eyes, nerves and heart. Our new study published in JAMA Internal Medicine found that less than one in four American adults diagnosed with diabetes reach the care targets recommended by
June 6, 2019 by Chain Drug Review
diabetes
June 3, 2019
Pharmacy accounts for the vast majority of chain drug store sales, and diabetes care is among the larger contributors to pharmacy volume. But the category is not without challenges. Most recently, insulin price inflation has raised a barrier to the purchase of — and adherence to — this life-saving prescription. The issue led Democratic and
March 18, 2019 by Dr. Juan Frias
American Liver Foundation, diabetes, Nonalcoholic fatty liver disease (NAFLD)
March 18, 2019, Pharmacy

The American Liver Foundation estimates that over 30% of the U.S. population has some degree of nonalcoholic fatty liver disease (NAFLD), the most common type of liver disease in the Western world. This can impact other facets of their overall health, because NAFLD has been linked to diabetes, obesity, insulin resistance and other metabolic risk
March 18, 2019 by Dave Chase
diabetes, insulin
March 18, 2019, Pharmacy

Last month, one furloughed government worker made national headlines by saying she had to ration her insulin because she couldn’t afford her co-pay, nor the ER bill, during the government shutdown. Recalling a day where her blood sugar was high, she admitted, “I just went to bed and hoped I’d wake up.” This is not
August 13, 2018 by Tina Moen
diabetes, IBM Watson Health, Sugar.IQ app, Tina Moen
Pharmacy, Technology

NEW YORK — The pharmacist plays an essential role in the continuum of care for many patients and is central to health care. While many patients might not realize it, a visit to the pharmacy is likely their most frequent opportunity to interact with a health care professional. Pharmacists are the most accessible health care